Forbright EVP Ogrosky reports initial share holdings
Forbright, Inc. executive vice president and chief legal officer Kori Ogrosky filed an initial Form 3 reporting current equity holdings in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Forbright, Inc. executive vice president and chief legal officer Kori Ogrosky filed an initial Form 3 reporting current equity holdings in the company. Ogrosky directly holds 83,793 shares of Class A common stock, including multiple restricted stock awards that vest over three- and five-year schedules.
Ogrosky also holds several stock option grants to buy Class A common stock at exercise prices between $12.36 and $17.04 per share, with expiration dates in 2031 and 2032. Some of these options and restricted awards are subject to performance-based vesting conditions tied to pre-established stock price hurdles.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Ogrosky Kori
Role
EVP and CLO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 170,000 contracts (Direct);
Class A Common Stock — 83,793 shares (Direct)
Footnotes (5)
- F1. Includes (i) 25,130 restricted stock awards ("RSAs") granted on March 13, 2025 that vest in five substantially equal annual installments on the first five anniversaries of the grant date; (ii) 13,500 RSAs granted on March 12, 2026 that vest in three substantially equal annual installments on the first three anniversaries of the grant date; and (iii) 46,875 RSAs granted on April 29, 2026 that vest in three substantially equal annual installments on the first three anniversaries of the grant date.
- F2. These options were granted on July 1, 2021 and vest in five equal annual installments on the first five anniversaries of the grant date, of which 20,000 options are also subject to performance-based vesting conditions based on pre-established stock price hurdles.
- F3. These options were granted on July 1, 2021 and vest in five equal annual installments on the first five anniversaries of the grant date.
- F4. These options were granted on February 16, 2022 and vest in five equal annual installments on the first five anniversaries of the grant date, of which 17,000 options are also subject to performance-based vesting conditions based on pre-established stock price hurdles.
- F5. These options were granted on February 16, 2022 and vest in five equal annual installments on the first five anniversaries of the grant date.
Key Figures
Direct Class A shares: 83,793 shares
RSA grant 1: 25,130 shares
RSA grant 2: 13,500 shares
+5 more
8 metrics
Direct Class A shares
83,793 shares
Total Class A common stock held directly following reported holdings
RSA grant 1
25,130 shares
Restricted stock awards granted March 13, 2025, vesting over five years
RSA grant 2
13,500 shares
Restricted stock awards granted March 12, 2026, vesting over three years
RSA grant 3
46,875 shares
Restricted stock awards granted April 29, 2026, vesting over three years
Option tranche 1
33,000 underlying shares at $17.04
Stock options expiring February 16, 2032, direct ownership
Option tranche 2
17,000 underlying shares at $13.50
Stock options expiring February 16, 2032, direct ownership
Option tranche 3
55,000 underlying shares at $17.04
Stock options expiring July 1, 2031, direct ownership
Option tranche 4
65,000 underlying shares at $12.36
Stock options expiring July 1, 2031, direct ownership
Key Terms
restricted stock awards, Stock Option (right to buy), performance-based vesting conditions, pre-established stock price hurdles, +1 more
5 terms
restricted stock awards financial
"Includes (i) 25,130 restricted stock awards ("RSAs") granted on March 13, 2025 that vest in five substantially equal annual installments..."
Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.
Stock Option (right to buy) financial
"security_title": "Stock Option (right to buy)""
performance-based vesting conditions financial
"of which 20,000 options are also subject to performance-based vesting conditions based on pre-established stock price hurdles."
pre-established stock price hurdles financial
"subject to performance-based vesting conditions based on pre-established stock price hurdles."
beneficial ownership financial
"initial statement of beneficial ownership of securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Forbright (FRBT) executive Kori Ogrosky report on the Form 3 filing?
Kori Ogrosky reported existing holdings of Forbright Class A common stock and stock options. The filing lists 83,793 directly held shares plus multiple restricted stock awards and several option grants with exercise prices between $12.36 and $17.04, expiring in 2031 and 2032.
What restricted stock awards are disclosed for Kori Ogrosky in Forbright’s Form 3?
The Form 3 notes restricted stock awards granted on March 13, 2025, March 12, 2026, and April 29, 2026. These RSAs vest in substantially equal annual installments over three or five years, aligning Ogrosky’s equity compensation with long-term employment and company performance.
Are any of Kori Ogrosky’s Forbright equity awards performance-based?
Yes. The footnotes state that portions of the July 1, 2021 and February 16, 2022 option grants are subject to performance-based vesting. Vesting depends on meeting pre-established stock price hurdles, tying part of Ogrosky’s potential equity gains directly to Forbright’s market performance.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates